California-based manufacturers of next-generation DNA sequencing (NGS) technology platforms Illumina and Pacific Biosciences of California (PacBio) recently decided to terminate their $1.2-billion...
On Tuesday, the Federal Trade Commission (FTC) took legal action to block Illumina Inc.’s acquisition of Pacific Biosciences of California (PacBio) as part of an administrative complaint alleging...
By the midway point of 2019, more than $200 billion had exchanged hands, exceeding previous years of $198 billion and $178 in 2018 and 2017, respectively. And the recent closing of Bristol-Myers Squibb...
